Mr. Akshay Daftary
Akshay serves as a Director in SIRO Clinpharm and is in charge of Global Business Development Activities and Client Management. Akshay is responsible to provide oversight, leadership, and guidance in the management of the company.
He started his career at Bharat Serums and Vaccines in the business development department in 2014 and moved on to SIRO in 2018 to look after the Business Development, Biometrics and Clinical Operations verticals.
Akshay has an undergraduate degree from Emory University in Economics and Mathematics.
Mr. Akshay Daftary
Mr. Karan Daftary – Director
Karan serves as a Director in SIRO Clinpharm and is in charge of Ancillary services including Finance, Human Resources, Quality Assurance, IT, Legal and Corporate Marketing. Karan’s responsibility is to ensure alignment of support functions to enhance business needs and requirements. He joined SIRO Clinpharm in 2018.
Karan developed his business acumen by working with the Puma Group as a Student Management Consultant to address business challenges. He also played an instrumental role in setting up a start-up at Babson College titled BOXO’s, to provide customizable care packages for students.
Karan has an undergraduate degree from Babson College, MA with a concentration in Finance and Entrepreneurship.
Mr. Karan Daftary
Dr. Vatsal Shah -
Global Chief Operating Officer
and Country Head (USA)
Dr. Vatsal is a physician by education and comes with more than 20+ years’ experience of clinical research and is based out of SIRO’s office in Princeton, New Jersey, United States. While being the COO of the organization, he is also the Business Head in the US. He has been a part of SIRO for 10+ years over 2 stints.
Vatsal started as an academician at KEM hospital immediately after his MD, and has had stints with Reliance, Cognizant, and Novartis.
Dr. Vatsal’s key achievements include establishing departments and leading their expansion plans, operational efficiency, and sales growth including SIRO’s medical writing team. This includes SIRO’s medical writing, medical monitoring, and pharmacovigilance groups back in 2001, Reliance’s medical affairs and pharmacovigilance department in 2008, Novartis’ first-of-its-kind medical writing and publication writing unit in India in 2005.
Dr. Vatsal Shah
Mr. Rahul Srivastava – President –
Strategy and Process Improvement
Rahul’s primary responsibility is to strategize and professionally enhance SIRO’s internal functioning through process improvement, as well as seize collaboration opportunities to grow the business in alternative geographies. Prior to joining SIRO, Rahul was Group Vice President at Bharat Serums and Vaccines Ltd, a company which he was a part of for 15+ years.
Rahul brings with him a wealth of 20+ years Techno-commercial experience in pharmaceutical and life sciences industry in corporate strategy, business development (including strategic alliances and product out-licensing) and project management of development projects from concept to market.
Rahul has an outstanding academic record of being a Ranker both at his MBA (Finance and Information Technology), IIT Roorkee as well as B.Tech. (Biochemical Engineering), HBTI Kanpur.
Mr. Rahul
Srivastava
Dr. Ganesh Divekar – Vice President
- Clinical Operations and Biometrics
Dr. Ganesh’s primary responsibility will be to provide Leadership to the Clinical Operations, Medical Services, Biometrics and Solutions Design teams.
Dr. Ganesh has over 17 years of extensive experience in design, execution of trials and dealing with global regulatory authorities in matters related to concept, design, and final clinical trial results, supports SIRO in meeting and exceeding customers’ expectations. Prior to joining SIRO, Ganesh was working over the last five years as Head Clinical Research and Pharmacovigilance, at Bharat Serums and Vaccines Ltd.
Dr. Ganesh completed his Bachelor of Medicine and Bachelor of Surgery from B.J. Medical College & Sassoon Hospitals; Pune and his Master of Business Administration from Jamanalal Bajaj Institute of Management Studies (Mumbai).